Browse > Article
http://dx.doi.org/10.3746/jkfn.2008.37.6.721

Effects of Hepcidin Hormone on the Gene Expression of Ferroportin and Divalent Metal Transporter 1 in Caco-2 Cells and J774 Cells  

Chae, Sun-Ju (Dept. of Food & Nutrition, Kyung Hee University)
Chung, Ja-Yong (Dept. of Food & Nutrition, Kyung Hee University)
Publication Information
Journal of the Korean Society of Food Science and Nutrition / v.37, no.6, 2008 , pp. 721-728 More about this Journal
Abstract
Hepcidin is a peptide hormone produced by the liver, of which secretion is closely related to iron status in the body. However, little is known about the molecular mechanism(s) by which this peptide regulates body iron homeostasis. The purpose of this study was to determine the effects of hepcidin treatment within the physiological concentration range on the expressions of two different iron transporter proteins-ferroportin (FPN) and divalent metal transporter 1 (DMT1). Differentiated Caco-2 intestinal cells and macrophage J774 cells were treated with either synthetic hepcidin or hepcidin-rich fraction separated from human urine at the concentration of 10 nM and 100 nM for 24 hours. Results show that hepcidin treatment in differentiated Caco-2 cells or in J774 cells did not change the level of either FPN mRNA or DMT1 mRNA. On the other hand, hepcidin treatment at the dose of 100 nM significantly decreased the FPN protein levels and DMT1 protein levels in differentiated Caco-2 cells. Similarly, urinary hepcidin treatment (10 nM & 100 nM) also significantly decreased the levels of FPN and DMT1 proteins in J774 macrophage cells. These results showed that hepcidin might play an important role in the regulation of iron homeostasis by lowering the protein levels of iron transporter FPN and DMT1 both in enterocytes and in macrophage cells.
Keywords
iron homeostasis; ferroportin; divalent metal transporter 1; hepcidin;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Yeh KY, Yeh M, Glass J. 2004. Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat. Am J Physiol Gastrointest Liver Physiol 286: 385-394   DOI   ScienceOn
2 Dallalio G, Fleury T, Means RT. 2003. Serum hepcidin in clinical specimens. Br J Haematol 122: 996-1000   DOI   ScienceOn
3 Chaston T, Chung B, Mascarenhas M, Marks J, Patel B, Srai SK, Sharp P. 2008. Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut 57: 374-382   DOI   ScienceOn
4 Park CH, Valore EV, Waring AJ, Ganz T. 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806-7810   DOI   ScienceOn
5 Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S. 2002. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 99: 4596-4601   DOI   ScienceOn
6 Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O. 2001. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811-7819   DOI   ScienceOn
7 Frazer DM, Wilkins SJ, Becker EM, Vulpe CD, McKie AT, Trinder D, Anderson GJ. 2002. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 123: 835-844   DOI   ScienceOn
8 Jumarie C, Malo C. 1991. Caco-2 cells cultured in serum- free medium as a model for the study of enterocytic differentiation in vitro. J Cell Physiol 149: 24-33   DOI
9 Yamaji S, Sharp P, Ramesh B, Srai SK. 2004. Inhibition of iron transport across human intestinal epithelial cells by hepcidin. Blood 104: 2178-2180   DOI   ScienceOn
10 Chua AC, Graham RM, Trinder D, Olynyk JK. 2007. The regulation of cellular iron metabolism. Crit Rev Clin Lab Sci 44: 413-459   DOI   ScienceOn
11 Papanikolaou G, Pantopoulos K. 2005. Iron metabolism and toxicity. Toxicol Appl Pharmacol 202: 199-211   DOI   ScienceOn
12 Weinberg ED. 2008. Iron out-of-balance: A risk factor for acute and chronic diseases. Hemoglobin 32: 117-122   DOI   ScienceOn
13 Roy CN, Enns CA. 2000. Iron homeostasis: new tales from the crypt. Blood 96: 4020-4027
14 Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A. 2001. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108: 619-623   DOI
15 Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. 2004. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093   DOI   ScienceOn
16 Ganz T. 2005. Hepcidin: a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 18: 171-182   DOI   ScienceOn
17 Abboud S, Haile DJ. 2000. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275: 19906-19912   DOI   ScienceOn
18 Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI. 2000. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403: 776-781   DOI   ScienceOn
19 McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ. 2000. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5: 299-309   DOI   ScienceOn
20 Ganz T. 2004. Hepcidin in iron metabolism. Curr Opin Hematol 11: 251-254   DOI   ScienceOn
21 Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S. 2001. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 98: 8780-8785   DOI   ScienceOn
22 Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. 2004. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271-1276   DOI
23 Nemeth E, Ganz T. 2006. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 26: 323-342   DOI   ScienceOn
24 Knutson MD, Vafa MR, Haile DJ, Wessling-Resnick M. 2003. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102: 4191-4197   DOI   ScienceOn
25 Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC. 1998. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A 95: 1148-1153   DOI
26 Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, Breuning MH, Snijders PJ, Rutten WP, Sandkuijl LA, Oostra BA, van Duijn CM, Heutink P. 2001. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28: 213-214   DOI   ScienceOn
27 Devalia V, Carter K, Walker AP, Perkins SJ, Worwood M, May A, Dooley JS. 2002. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 100: 695-697   DOI   ScienceOn
28 Roetto A, Totaro A, Piperno A, Piga A, Longo F, Garozzo G, Cali A, De Gobbi M, Gasparini P, Camaschella C. 2001. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 97: 2555-2560   DOI   ScienceOn